Drug-induced autoimmune hemolytic anemia
From Wikipedia, the free encyclopedia
| Drug-induced autoimmune hemolytic anemia | |
|---|---|
| Classification and external resources | |
| ICD-10 | D59.0 |
| ICD-9 | 283 |
Drug-induced autoimmune hemolytic anemia is a form of hemolytic anemia.
Penicillin in high doses can induce immune mediated hemolysis[1] via the hapten mechanism in which antibodies are targeted against the combination of penicillin in association with red blood cells. Complement is activated by the attached antibody leading to the removal of red blood cells by the spleen.
The drug itself can be targeted by the immune system, e.g. by IgE in a Type I hypersensitivity reaction to penicillin, rarely leading to anaphylaxis.
See also[edit]
References[edit]
- ^ Stroncek D, Procter JL, Johnson J (May 2000). "Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction". Am. J. Hematol. 64 (1): 67–70. doi:10.1002/(SICI)1096-8652(200005)64:1<67::AID-AJH12>3.0.CO;2-Z. PMID 10815791.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
